
Aptevo Therapeutics Inc (APVO)
NASDAQ
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 6.677 | -58.199 | -66.91 | -33.192 | -51.67 | 17.678 | -58.963 | -119.358 |
Return on Equity (%) | 10.517 | -95.497 | -191.479 | -124.842 | -319.562 | 83.658 | -115.324 | -284.284 |
Return on Invested Capital (%) | -38.093 | -78.803 | -199.632 | -150.884 | -105.013 | -235.874 | -179.274 | -289.844 |
Operating Margin (%) | -381.314 | -232.752 | -137.855 | -717.638 | -239.245 | 225.241 | N/A | N/A |
Net Profit Margin (%) | 47.571 | -232.752 | -124.747 | -411.929 | -231.508 | 257.771 | N/A | N/A |
Book Value Per Share | 3.515 | 1.103 | 0.164 | 3.762 | 0.248 | 2.78 | 0.694 | 0.257 |
Earnings Per Share | 0.323 | -2.354 | -0.893 | -4.024 | -5.81 | 1.241 | -0.988 | -1.303 |
Cash Per Share | 0.328 | 1.343 | 0.275 | 9.063 | 9.196 | 3.501 | 0.96 | 0.471 |
Working Capital Per Share | 3.544 | 1.363 | -0.182 | 8.036 | 3.637 | 2.899 | 0.672 | 0.24 |
Operating Profit Per Share | 0.553 | 0.625 | 0.325 | 0.977 | 2.51 | 0.482 | N/A | N/A |
EBIT Per Share | -2.587 | -2.354 | -0.987 | -7.01 | -6.004 | 1.085 | -1.059 | -1.303 |
EBITDA Per Share | -2.587 | -2.354 | -0.987 | -7.01 | -6.004 | 1.085 | -1.059 | -1.303 |
Free Cash Flow Per Share | 0.281 | -2.416 | -0.939 | -4.276 | -5.889 | 1.107 | -1.02 | -1.322 |
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 21,61M | 22,81M | 45,28M | 4,41M | 4,9M | 6,47M | N/A | N/A |
Fin d'année 31 Décembre 2024 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 3,47M |
Ratio cours/bénéfice | -0,15 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,4 |
Ratio prix/valeur comptable | 0,74 |
Rendement de dividende | - |
Actions en circulation | 1,46M |
Volume moyen (1 semaine) | 18,48k |
Volume moyen (1 mois) | 46,06k |
Variation sur 52 semaines | -98,63% |
Plus haut sur 52 semaines | 207,3332 |
Plus bas sur 52 semaines | 2,354 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales